Alma Duo is a focused low-intensity extracorporeal shockwave therapy (LI-ESWT) device for erectile dysfunction. It uses acoustic energy rather than laser or radiofrequency, and it is used in clinics under the direction of a healthcare professional.
How shockwave therapy for ED works
A handheld applicator delivers focused low-intensity acoustic pulses to the penile tissue. In the published literature, this mechanical stimulus is associated with the formation of new microvasculature and improved blood flow, which is why shockwave therapy for ED is studied mainly in men with erectile dysfunction of vascular origin.
The Alma Duo ED shockwave therapy protocol
The standard protocol is six sessions of about 15 minutes, twice a week over three weeks. Sessions take place in a standard consulting room and need no anaesthetic. Results vary between patients, and the treating clinician sets the plan after assessment.
Who is ED shockwave therapy for?
Published studies of LI-ESWT report the most consistent improvements in men with mild to moderate erectile dysfunction of vascular origin. Patient selection matters: the treating clinician screens for contraindications and decides whether the treatment is appropriate.
A shockwave therapy device for clinics
As a shockwave therapy device, the device fits into a standard consulting room and is delivered as a course. Which clinicians can deliver treatments depends on scope of practice in each state, and Alma Lasers Australia provides clinical references, training and local service to clinics that install it.
What happens during a session
The clinician delivers focused low-intensity pulses through a handheld applicator. No anaesthetic is used, and a session takes about 15 minutes. Because sessions are short and run as a course, they fit comfortably between other appointments in a clinic schedule.
Evidence behind low-intensity shockwave therapy
Low-intensity shockwave therapy for erectile dysfunction has been studied in randomised controlled trials and meta-analyses over more than a decade. The clinical resources on this page list three of those reviews, published in The Journal of Sexual Medicine (2017), Therapeutic Advances in Urology (2019) and the International Journal of Impotence Research (2019).